alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[115th Congress Public Law 291]
[From the U.S. Government Publishing Office]

[[Page 132 STAT. 4375]]

Public Law 115-291
115th Congress

                                 An Act

 
To designate the facility of the United States Postal Service located at 
  1325 Autumn Avenue in Memphis, Tennessee, as the ``Judge Russell B. 
 Sugarmon Post Office Building''. <<NOTE: Dec. 6, 2018 -  [H.R. 5349]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. JUDGE RUSSELL B. SUGARMON POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 1325 Autumn Avenue in Memphis, Tennessee, shall be known and 
designated as the ``Judge Russell B. Sugarmon Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Judge 
Russell B. Sugarmon Post Office Building''.

    Approved December 6, 2018.

LEGISLATIVE HISTORY--H.R. 5349:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 164 (2018):
            Sept. 13, considered and passed House.
            Nov. 15, considered and passed Senate.

                                  <all>
```
August 28, 2012

Mr. Paul Gretch Ms. Esta Rosenberg
Office of International Aviation U.S. Department of Transportation 1200 New Jersey Avenue, SE Washington, DC 20590

Re: Application of US Airways, Inc. for Amendment of a Statement of Authorization (Display VS Code on US Airways-Operated Flights between the United States and the United Kingdom) (Docket DOT-OST-2007-27349)

Dear Mr. Gretch and Ms. Rosenberg:

We have polled the air carriers on t he attached service list regarding the above-referenced Application. We received no objections.

Accordingly, we respectfully reques t expedited consideration of this Application.

Sincerely,

/s/ Benjamin T. Slocum

Howard Kass Vice President – Legal and Government Affairs

Benjamin T. Slocum

Director and Assistant General Counsel

Attachment
cc: Service List

1401 H Street NW, Suite 1075 Washington, DC 20005 (202) 326-5154 Fax: (202) 898-4810CERTIFICATE OF SERVICE

I certify that, on August 28, 2012, I caused to be served a copy of the foregoing Letter by email upon those addressees listed below:

urskr@state.gov (Department of State) esta.rosenberg@dot.gov (Department of Transportation) mary.street@dot.gov (Department of Transportation) brett.kruger@dot.gov (Department of Transportation) john.allen@faa.gov (Federal Aviation Administration)
dan.weiss@united.com (United) steve.morrissey@united.com (United) jonathan.linde@united.com (United)
francis.heil@aa.com (American)
robert.wirick@aa.com (American)
sascha.vanderbellen@delta.com (Delta)
anita.mosner@hklaw.com (Counsel for Virgin Atlantic and UPS) jennifer.nowak@hklaw.com (Counsel for Virgin Atlantic and UPS)
cefelts@fedex.com (FedEx) nssparks@fedex.com (FedEx) kevin.montgomery@polaraircargo.com (Polar) rpommer@atlasair.com (Atlas) /s/ Benjamin T. Slocum

Benjamin T. Slocum
**Exhibit 31.2**

 

**SECTION 302 CERTIFICATION**

 

I, John W. Burns, certify that: 

 

1. I have reviewed this annual report on Form 10-K of GlycoGenesys, Inc. 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit tostate a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officer(s) and Iare responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(e) for the registrant and have: 

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report isbeing prepared; 

 

**(b)****[Paragraphreserved pursuant to SEC Release 33-8238];**

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period coveredby this report based on such evaluation; and 

 

(d) Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the caseof an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

(c) All significant deficiencies and material weaknesses inthe design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

(d) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: March 30, 2005
§ 182.3637 Potassium metabisulfite. ( a ) *Product.* Potassium metabisulfite.
( b ) [Reserved]
( c ) *Limitations, restrictions, or explanation.* This substance is generally recognized as safe when used in accordance with good manufacturing practice, except that it is not used in meats; in food recognized as a source of vitamin B1; on fruits and vegetables intended to be served raw to consumers or sold raw to consumers, or to be presented to consumers as fresh.
[42 FR 14640, Mar. 15, 1977, as amended at 51 FR 25025, July 9, 1986; 55 FR 9832, Mar. 15, 1990; 59 FR 65939, Dec. 22, 1994]
<partyblock><br><br><div align="center"><b><font size="+1">The People of the State of New York, Respondent,<br><br>against<br><br>Jamel Jones, Appellant.</font></b></div><br><br><p>Appellate Advocates (Nao Terai, Esq.) for appellant.District Attorney Kings County (Jodi L. Mandel, Esq.) for respondent.</p><p>Appeal from a judgment of the Criminal Court of the City of New York, Kings County (Laura Johnson, J.), rendered July 8, 2015. The judgment convicted defendant, upon his plea of guilty, of criminal possession of stolen property in the fifth degree. Assigned counsel has submitted a brief in accordance with Anders v California (386 US 738 [1967]), seeking leave to withdraw as counsel.</p><p>ORDERED that the judgment of conviction is affirmed.</p><p>We are satisfied with the sufficiency of the brief filed by defendant's assigned counsel pursuant to <i>Anders v California </i>(386 US 738 [1967]), and, upon an independent review of the record, we conclude that there are no nonfrivolous issues which could be raised on appeal. Counsel's application for leave to withdraw as counsel is, therefore, granted (<i>see id.; Matter of Giovanni S. </i>[<i>Jasmin A</i>.], 89 AD3d 252 [2011]; <i>People v Paige</i>, 54 AD2d 631 [1976]; <i>cf. People v Gonzalez</i>, 47 NY2d 606 [1979]).</p><p>Weston, J.P., Solomon and Elliot, JJ., concur.</p><br>Paul Kenny<br>Chief Clerk<br>Decision Date: April 21, 2017<br><br><div align="center"><form method="LINK" action="../../slipidx/at_2_idxtable.shtml"><input type="submit" value="Return to Decision List"></form></div></partyblock>
<PAGE>   1
FRONTIER FINANCIAL CORPORATION AND SUBSIDIARIES                       EXHIBIT 11
COMPUTATION OF EARNINGS PER SHARE



<TABLE>
<CAPTION>
                                              For Nine Months Ended September 30,

                                                   1998                1997
<S>                                             <C>                <C>
Net Income                                      $14,689,370        $13,058,523
                                                ===========        ===========

Computation of average
shares outstanding

    Shares outstanding at
    beginning of year                             7,350,561          6,830,666

    Additional shares deemed
    outstanding because of
    stock dividends                                 516,035            992,046

    Additional shares deemed
    outstanding because of
    stock split                                           0                  0

    Shares issued during the
    year times average time
    outstanding during the year                      14,464             12,189
                                                -----------        -----------

Average basic shares outstanding                  7,881,060          7,834,901
                                                -----------        -----------

Dilutive shares                                      83,405             71,261

                                                -----------        -----------

Average fully diluted shares outstanding          7,964,465          7,906,162
                                                -----------        -----------
Basic earnings per share                        $      1.86        $      1.67
                                                ===========        ===========


Fully diluted earnings per share                $      1.84        $      1.65
                                                ===========        ===========
</TABLE>
**Exhibit 99.1**

** **

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

The undersigned officer ofAltris Software, Inc. (the “Company”) hereby certifies to his knowledge thatthe Company’s quarterly report on Form 10-Q for the period ended March 31, 2003(the “Report”), as filed with the Securities and Exchange Commission on thedate hereof, fully complies with the requirements of Section 13(a) or 15(d), asapplicable, of the Securities Exchange Act of 1934, as amended, and that theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.  This certification is provided solelypursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, and shall not be deemed to be a part of the Reportor “filed” for any purpose whatsoever.

 
| Dated:             | May 15, 2003 |   |
|-------------------------|--------------|--------|
|                    |         |   |
| /s/ Carl Mostert        |         |
| Carl Mostert            |
| Chief Executive Officer |

 

A signed original of thiswritten statement required by Section 906 has been provided to Altris Software,Inc. and will be retained by Altris Software, Inc. and furnished to theSecurities and Exchange Commission or its staff upon request.

 

----
#### § 26.72 Sectoral contact points.

Each party shall appoint and confirm in writing contact points to be responsible for activities under subparts A and B of this part.
P.1 

OAR Box 1830 

Prepped by Ollie Stewart 

Document Number: 

12DIV-C-87 

Docket Number: 

A-87-11 

Printed 11/13/2008 7:20:57AM Sheet 121 of 232 
P.2 

j^T % 

I XSffl 1 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

**^^s^ • 5 k r-4 

% PRO*0 

WASHINGTON, D.C. 20460 

FEB; 2 6 1988 

OFFICE OF 

AIR AND RADIATION 

Honorable Bob Dole 

United States Senate 

Washington, D.C. 20510 

Dear Senator Dole: 

Thank you for passing along the comments from your 

constituent, Mr. John J. Roach, concerning EPA's proposal to 

require onboard refueling emission controls. Be assured that 

these comments will be considered as we prepare our final rule. 

We will also be placing them in the public docket for the 

rulemaking (Docket No. A-87-11). 

Thank you again for your concern in this matter. 

Sincerely yours, 

0V;;

;-:-'Av, G-Gr.cD B Y 

'.-•• •

 :

 .- • • ••". ' "A;! 

Richard D. Wilson 

Director, Office of Mobile Sources 

cc: Docket A-87-11 

Prepared by: Form Letterrsal:2/18/88:AL880656 - Ann Arbor, MI 

bcc: Region 07 

Congressional Liaison/Quinn 

Docket A-87-11 c/o Jackie McManus
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Factory 2-U Stores, Inc.
(the  "Company")  for the  quarter  ended  November  1, 2003,  as filed with the
Securities Exchange Commission on the date hereof (the "Report"),  I, Douglas C.
Felderman,  Executive Vice President and Chief Financial Officer of the Company,
certify,  pursuant to and for  purposes of 18 U.S.C.  Section  1350,  as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material  aspects,  the  financial  condition of the Company as of the
          dates  indicated  and  result of  operations  of the  Company  for the
          periods indicated.




                                              /s/ Douglas C. Felderman
                                              ------------------------
                                              Douglas C. Felderman
                                              Executive Vice President and
                                              Chief Financial Officer
                                              December 16, 2003
[J-17-2021]

IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Appellee

v.

ALLEN BROWN,

Appellant

:

:

:

:

:

:

:

:

:

:

:

24 WAP 2020

Appeal from the Order of the Superior 

Court entered 3/10/20 at No. 916 WDA 

2019, affirming the order of the Court of 

Common Pleas of Allegheny County 

entered 6/6/19 at No. CP-02-CR-0008971-

2005

SUBMITTED: January 21, 2021

ORDER

PER CURIAM

AND NOW, this 25th day of March, 2021, this appeal is dismissed as having 

been improvidently granted.
Affirmed and Memorandum Opinion filed September 5 , 2013
.

In The 

## Fourteenth Court of Appeals

NO. 14

- 13

- 00377

- CV

IN THE INTEREST OF R .N.T. AND S.P.T., C hildren

On Appeal from the 313th District Court

Harris County, Texas Trial Court Cause No. 2012

- 03540J

M E M O R A N D U M O P I N I O N

Appellant, J.S.T. , appeals a final decree terminating h er parental rights to the child ren who are the subject of this suit. Appellant filed a timely notice of appeal. Appellant ’ s appointed counsel filed a brief in which he concludes the appeal is wholly frivolous and without merit. The brief meets the requirements of Anders v. California , 386 U.S. 738, 87 S.Ct. 1396 (1967), presenting a professional evaluation of the record demo nstrating why there are no arguable grounds to be advanced. See High v. State , 573 S.W.2d 807 (Tex. Crim. App. 1978). The2

Anders procedures are applicable to an appeal from the termination of parental rights when an appointed attorney concludes that ther e are no non
- frivolous issues to assert on appeal. In re D.E.S. , 135 S.W.3d 326, 329 (Tex. App.

C Houston [14th Dist.] 2004, no pet.). A copy of counsel ’ s brief and the record w ere delivered to appellant. Appellant was advised of h er right to examine the appellate record and file a pro se
response. See Stafford v. State , 813 S.W.2d 503, 510 (Tex. Crim. App. 1991); In re D.E.S. , 135 S.W.3d at 329

- 30. More than forty

- five days have elapsed and as of this date, no pro se response has been filed.
We have ca refully reviewed the record and counsel ’ s brief and agree the appeal is wholly frivolous and without merit. Further, we find no reversible error in the record. A discussion of the brief would add nothing to the jurisprudence of the state. Accordingly, th e judgment of the trial court is affirmed.

PER CURIAM

Panel consists of Justices Brown, Christopher, and Donovan

.
**Exhibit 32****Certifications Pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350)**     The undersigned, as the President and Chief Executive Officer, and Acting Chief FinancialOfficer and Vice President Corporate Controller of Exide Technologies, each certify that     (1) the accompanying Quarterly Report on Form 10-Q for the period ended December 31, 2005,fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the SecuritiesExchange Act of 1934, as amended; and     (2) the information contained in the periodic report fairly presents, in all materialrespects, the financial condition and results of operations of Exide Technologies at the dates andfor the periods indicated.     A signed original of this written statement required by Section 906 has been provided to ExideTechnologies and will be retained by Exide Technologies and furnished to the Securities andExchange Commission or its staff upon request.     The undersigned expressly disclaims any obligation to update the foregoing certificationexcept as required by law.Date: February 9, 2006     /S/ Gordon A. Ulsh     Gordon A. Ulsh  President and Chief Executive Officer     /S/ Phillip A. Damaska     Phillip A. Damaska  Acting Chief Financial Officer and  Vice President Corporate Controller
§ 520.666 Dirlotapide. ( a ) *Specifications.* Each milliliter (mL) of solution contains 5 milligrams (mg) dirlotapide.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* The initial dosage is 0.01 mL/kg (0.0045 mL/lb) body weight for the first 14 days. After the first 14 days of treatment, the dose volume is doubled to 0.02 mL/kg (0.009 mL/lb) body weight for the next 14 days (days 15 to 28 of treatment). Dogs should be weighed monthly and the dose volume adjusted every month, as necessary, to maintain a target percent weight loss until the desired weight is achieved.
( 2 ) *Indications for use.* For the management of obesity.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[72 FR 263, Jan. 4, 2007, as amended at 79 FR 28820, May 20, 2014]
EXHIBIT 32



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350



In connection with the Annual Report on Form 10-KSB for the period ended June 30, 2004 (the Report) of The Southern Banc Company, Inc. (the
Company), as filed with the Securities and Exchange Commission on the date hereof, the undersigned, Chief Executive Officer and Chief Financial Officer of the Company, hereby certifies that to the best of my knowledge:



| | (1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods covered
in the Report.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                    |  |     |  |                                                      
|------------------- |  | --- |  | -----------------------------------------------------
|Date: April 1, 2005 |  | By: |  | /s/ Gates Little                                     
|                    |  |     |  | Gates Little                                         
|                    |  |     |  | President and Chief Executive Officer                
|                    |  |     |  | (Chief Executive Officer and Chief Financial Officer)



A signed original of
the written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. The information
furnished herein shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.



44
§ 1313.27 Return declaration for exports. ( a ) *Return information.* Within 30 calendar days after a listed chemical is released by a customs officer at the port of export, the exporter must file a report with the Administration through the DEA Diversion Control Division secure network application specifying the particulars of the transaction. This report must include the following information: The date on which the listed chemical left the registered location or place of business; the date on which the listed chemical was released by a customs officer at the port of export; the actual quantity of listed chemical that left the registered location or place of business; the actual quantity of the listed chemical released by a customs officer at the port of export; chemical; container; name of transferees; and any other information as the Administration may specify. Upon receipt and review, the Administration will assign a completed report a transaction identification number. The report will not be deemed filed until the Administration has issued a transaction identification number. In determining whether the exporter has complied with the requirement to file within 30 calendar days, the report shall be deemed filed on the first date on which a complete report is filed.
( b ) If an exportation for which a DEA Form 486 has been filed fails to take place, the exporter must report to the Administration that the exportation did not occur through the DEA Diversion Control Division secure network application.
( c ) *Denied release at the port of export.* In the event that a shipment of listed chemicals has been denied release by a customs officer at the port of export for any reason, the exporter who attempted to have the shipment released must, within 5 business days of the denial, report to the Administration that the shipment was denied release and the reason for denial. Such report must be transmitted to the Administration through the DEA Diversion Control Division secure network application. This report must include the following information: The quantity of the listed chemicals denied release; the date on which release was denied; and the basis for the denied release. Upon the exporter's report of a denied release, DEA will assign the report a transaction identification number and the export declaration will be void and of no effect. No shipment of listed chemicals denied release for any reason will be allowed to be released from the United States without a subsequent refiling of a complete and accurate export declaration. Following such refiling, the exporter may request the release of the listed chemicals immediately after receipt of a transaction identification number without regard to the 15 day advance filing required by § 1313.21(b).
[81 FR 97039, Dec. 30, 2016]